Nonpermissive HLA-DPB1 mismatch increases mortality after myeloablative unrelated allogeneic hematopoietic cell transplantation.
about
How to select the best available related or unrelated donor of hematopoietic stem cells?Alternative Donor Transplantation for Acute Myeloid LeukemiaAlternative Donor Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid LeukemiaThe indications for allogeneic stem cell transplantation in myeloid malignancies.Role of major histocompatibility complex variation in graft-versus-host disease after hematopoietic cell transplantation.Clinical implications of HLA locus mismatching in unrelated donor hematopoietic cell transplantation: a meta-analysisBiological significance of HLA locus matching in unrelated donor bone marrow transplantation.High HLA-DP Expression and Graft-versus-Host Disease.HLA Mismatch Is Associated with Worse Outcomes after Unrelated Donor Reduced-Intensity Conditioning Hematopoietic Cell Transplantation: An Analysis from the Center for International Blood and Marrow Transplant ResearchThe effect of donor characteristics on survival after unrelated donor transplantation for hematologic malignancy.Genetic editing of HLA expression in hematopoietic stem cells to broaden their human application.Human leukocyte antigen supertype matching after myeloablative hematopoietic cell transplantation with 7/8 matched unrelated donor allografts: a report from the Center for International Blood and Marrow Transplant ResearchRegulatory T-Cell Therapy for Graft-versus-host Disease.Allele-level HLA matching for umbilical cord blood transplantation for non-malignant diseases in children: a retrospective analysis.Personalized Prognostic Risk Score for Long-Term Survival for Children with Acute Leukemia after Allogeneic Transplantation.Identification of high-risk amino-acid substitutions in hematopoietic cell transplantation: a challenging task.Effect of antithymocyte globulin source on outcomes of bone marrow transplantation for severe aplastic anemia.BSHI Guideline: HLA matching and donor selection for haematopoietic progenitor cell transplantation.Mismatched unrelated donor transplantation.Identification of a 10/10 matched donor for patients with an uncommon haplotype is unlikely.Combining one-step Sanger sequencing with phasing probe hybridization for HLA class I typing yields rapid, G-group resolution predicting 99% of unique full length protein sequences.Recipient/donor HLA and CMV matching in recipients of T-cell-depleted unrelated donor haematopoietic cell transplants.In celebration of Ruggero Ceppellini: HLA in transplantation.Unrelated donor search prognostic score to support early HLA consultation and clinical decisions.Identification of novel variants in HLA class II region related to HLA DPB1 expression and disease progression in patients with chronic hepatitis C.A trial of unrelated donor marrow transplantation for children with severe sickle cell disease.Genetic risk factors for sclerotic graft-versus-host disease.Predicting relevant immunogenetic disparities.MHC Class I Chain-Related Gene A (MICA) Donor-Recipient Mismatches and MICA-129 Polymorphism in Unrelated Donor Hematopoietic Cell Transplantations Has No Impact on Outcomes in Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, or MyelodysplasticEvolutionary basis of HLA-DPB1 alleles affects acute GVHD in unrelated donor stem cell transplantation.Prediction of absolute risk of acute graft-versus-host disease following hematopoietic cell transplantation.Clinical outcomes of HLA-DPB1 mismatches in 10/10 HLA-matched unrelated donor-recipient pairs undergoing allogeneic stem cell transplant.Decision making in pediatric hematopoietic cell transplantation: Influential factors vary among diseases.RNA processing and protein expression of HLA-B*07:44N.No association between donor telomere length and outcomes after allogeneic unrelated hematopoietic cell transplant in patients with acute leukemia.Mismatched unrelated donor allogeneic stem cell transplant for high risk haematological malignancy: A single centre experience.Development of an Unrelated Donor Selection Score Predictive of Survival after HCT: Donor Age Matters Most.Evaluation of a Machine Learning-Based Prognostic Model for Unrelated Hematopoietic Cell Transplantation Donor Selection.Conflicting HLA assignment by three different typing methods due to the apparent loss of heterozygosity in the MHC region.Limited HLA sequence variation outside of antigen recognition domain exons of 360 10 of 10 matched unrelated hematopoietic stem cell transplant donor-recipient pairs.
P2860
Q26744109-E8735705-A73B-4D84-A5C2-EB88D32D80DCQ26799456-903E6991-597F-44FA-AD27-F4F54B293AD5Q28080943-E12DF9BE-21DE-4486-AF28-6BEA326801A5Q30316611-E424523B-7833-4F45-9754-E4FD8A811825Q33642419-CC195270-AF0C-459E-9AEA-3A69E26FB74BQ33689153-A02A76CA-50C2-4851-B290-5A4E6462D2BBQ35080101-11313F79-9584-41C3-81F3-948A274CDE9DQ36028056-64F73D69-037B-4747-AAE6-BFC9F7678AFBQ36055055-38629B73-983F-4F47-B6DA-658F66434AD4Q36463393-639D9CF1-4534-49D7-9B86-F9AC4B4F3135Q36605814-D2B72F4A-A601-480E-962D-C96E313A2F35Q37304135-F1FF7D95-D535-49B8-9EDC-E45743A9FC41Q37309438-B1D8C221-40B8-4488-9639-16C8E7308FCDQ38721768-0B47FB66-045D-46CC-8263-64EF71B028A9Q38773051-71496CCA-5857-4003-A61F-E16B87084DEFQ38841732-93EE3BBD-40A0-47A3-8B1A-26A1600C72AAQ38877341-1DD2EEDE-790B-4A63-818F-DB22381B267CQ38922475-3B6C5A34-2AB9-436B-9423-3D5406828839Q38992834-8AA549BF-1F00-44E1-B3D5-A948E7595FBEQ39013096-3377100E-58AB-4BE9-989D-6F801BAFCE3FQ39013101-40D95FE3-68E8-425D-8CA8-111151F2BC94Q39018399-5CDAE8E0-4B84-47BC-95DB-591C0B15A17BQ39094693-B936324C-8C9D-41B7-B093-296D7E1708CFQ39703220-0D63FD53-5794-45C7-9B02-8CDEAD2221BEQ40279001-BC005899-353F-4E22-99E5-D02DFC7832E2Q40582651-728E9866-5471-483F-BCBE-46B9DFFF9493Q41108286-D9E7F1B0-5B32-4989-917A-E4B0A03F6BFAQ42428458-6A0A1B85-2A7B-4658-AE80-1DBE1A121436Q46933088-7BFF6445-CB75-4960-BAB8-A67AB05458A6Q47300196-06740D7F-53A6-4065-BBAF-FC170DF9E4E8Q47561039-A4CAED7F-A567-4C61-B67A-DB6052906E32Q47795034-6F1A534B-9C7F-4337-A344-14506BDEE390Q48154699-6EAF9860-19D5-4853-B732-4F4BD6BD7280Q48230148-FFEFC956-08CB-462A-B7FD-480F2B1ED572Q48362158-95BAF111-985B-420E-9CCF-18A0F30B59E2Q49283386-3C2A88C0-0A25-4DC2-813A-B95DDD6BD0D8Q49904514-D5FA7BCB-A364-45A8-87B1-5C15C84A6867Q50148896-2D5BFC22-60B3-4D07-A288-1789CC40AC5FQ50249146-E1BA4EF2-3BA5-406E-9CD8-C5F06007F938Q50285341-F00C5F47-FB32-40C1-B8C6-AF16EC53D591
P2860
Nonpermissive HLA-DPB1 mismatch increases mortality after myeloablative unrelated allogeneic hematopoietic cell transplantation.
description
2014 nî lūn-bûn
@nan
2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Nonpermissive HLA-DPB1 mismatc ...... opoietic cell transplantation.
@ast
Nonpermissive HLA-DPB1 mismatc ...... opoietic cell transplantation.
@en
Nonpermissive HLA-DPB1 mismatc ...... opoietic cell transplantation.
@nl
type
label
Nonpermissive HLA-DPB1 mismatc ...... opoietic cell transplantation.
@ast
Nonpermissive HLA-DPB1 mismatc ...... opoietic cell transplantation.
@en
Nonpermissive HLA-DPB1 mismatc ...... opoietic cell transplantation.
@nl
prefLabel
Nonpermissive HLA-DPB1 mismatc ...... opoietic cell transplantation.
@ast
Nonpermissive HLA-DPB1 mismatc ...... opoietic cell transplantation.
@en
Nonpermissive HLA-DPB1 mismatc ...... opoietic cell transplantation.
@nl
P2093
P2860
P50
P1433
P1476
Nonpermissive HLA-DPB1 mismatc ...... opoietic cell transplantation.
@en
P2093
Adetola A Kassim
Ann E Woolfrey
Bronwen Shaw
Carlheinz Mueller
Carolyn K Hurley
Claudio Anasetti
Effie W Petersdorf
Hai-Lin Wang
Jan Storek
Jason Dehn
P2860
P304
P356
10.1182/BLOOD-2014-05-576041
P407
P577
2014-08-26T00:00:00Z